New Lupus Research Program in Appropriations Bill H.R. 1301 Passed by House of Representatives Press Release March 8, 2017 Demonstrates the Power of Patient Advocacy Lupus patients will have a new medical research program at work for them in...
Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints News and Stories Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global...